Atlas Trials

Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

Clinical trial NCT01418235 · COMPLETED

Trial details

NCT number
NCT01418235
Sponsor
HIV Vaccine Trials Network
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV SeronegativityHIV Preventive Vaccine
Start date
2011-12-19
Primary completion
2013-10-07
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.